The BIO Agency is 1st for creativity

Author BIOPublished 1 Min Read

The BIO Agency has been listed in Econsultancy’s Top 100 Digital Agencies Report for another consecutive year, rising to number 28 by fee income and number 1 in the creativity category.

The report also names BIO’s CEO Peter Veash as the Most Influential Person in the digital industry. On hearing the news, Peter Veash, The BIO Agency CEO, said: 

I’m absolutely honoured to receive such important recognition and very proud BIO ranked first in creativity this year. Econsultancy’s 2018 report showcases the massive changes the industry has witnessed in the last 12 months, but despite the increased market issues, we’re seeing a growing demand for customer-led transformation – one that actually delivers the results it promises. Peter Veash – CEO at The BIO Agency

The Econsultancy report also features a BIO case study in a collection of stories that highlight best-in-class examples of digital excellence. The case study outlines the agency’s work for the UK’s leading real estate agent Savills. BIO helped to future-proof Savills with a new online platform, redefining what customer experience means in the property sector. BIO delivered a modern and innovative property service offering state-of-the-art personalised customer experiences, building a business that seamlessly joins digital and physical for holistic service excellence.   

The Top 100 Digital Agencies report lists the largest and most successful digital agencies, ranked by their fee income from digital activities in the UK. Now in its sixteenth year, the report includes insightful analysis and commentary on the state of the industry. It also features information on each Top 100 agency to support brands in choosing the right agency partner to help achieve their business objectives.

The BIO Agency profile is available to read here
The interview with BIO’s CEO Peter Veash is available to read here
Savills case study is available to view here.
The full report is available to read and download here.

BIOShare article |
BIOShare article |